• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Paulson sells off 70 percent of Boston Scientific stake

Paulson sells off 70 percent of Boston Scientific stake

February 17, 2011 By MassDevice staff

BSX logo

One of Boston Scientific Corp.’s (NYSE:BSX) largest shareholders sold off nearly 70 percent of its stake in the medical device maker during the fourth quarter.

Paulson & Co. LLC now owns 25 million BSX shares, or about 1.5 percent of the Natick, Mass.-based firm. That position is worth $189.2 million, according to a regulatory filing.

The New York-based hedge fund has been steadily liquidating shares of BSX over the last year. The firm owned nearly 100 million shares worth $715.8 million as of the end of the first quarter, according to a filing with the federal Securities & Exchange Commission. The fund ditched more than 19.1 million shares during the second quarter, according to another SEC filing and sold off some 55 million shares during the fourth quarter ending Dec. 31, 2010.

BSX shares ranged from $6.13 Sept. 30 to about $7.57 Dec. 31, hitting a high-water mark of $7.82 Dec. 28. That leaves Paulson fetching between $337 million and $430 million for ithe sell-off.

The hedge fund is run by John Paulson, a billionaire financier who’s made frequent headlines over the past two years. Paulson was a player in the fallout over Goldman Sachs & Co.’s sub-prime mortgage fiasco last spring and his enormous personal wealth makes him all the more conspicuous. Last month the Wall Street Journal pegged his personal income at $5 billion for 2010.

Paulson’s firm was once Boston Scientific’s largest institutional shareholder, a position now held by Dodge & Cox, Inc., which recently increased its stake to 120 million shares, or 7.9 percent, of its neighbor in Natick.

Filed Under: Business/Financial News, News Well Tagged With: Boston Scientific, Paulson & Co. Inc.

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy